Shockwave Medical, Inc. (SWAV)
May 31, 2024 - SWAV was delisted (reason: acquired by JNJ)
334.75
0.00 (0.00%)
Inactive · Last trade price on May 30, 2024

ShockWave Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
May '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Market Capitalization
-7,0317,4316,2963,5531,350
Upgrade
Market Cap Growth
53.89%-5.38%18.03%77.18%163.22%-
Upgrade
Enterprise Value
-6,8797,2356,1433,3631,254
Upgrade
PE Ratio
-47.7434.40---
Upgrade
PS Ratio
-9.6315.1726.5552.4231.45
Upgrade
PB Ratio
-10.5214.5326.0315.757.01
Upgrade
P/TBV Ratio
-13.1114.5326.0315.757.01
Upgrade
P/FCF Ratio
-42.4980.252424.28--
Upgrade
P/OCF Ratio
-35.8663.12418.72--
Upgrade
EV/Sales Ratio
-9.4214.7725.9049.6129.20
Upgrade
EV/EBITDA Ratio
-39.0156.092268.34--
Upgrade
EV/EBIT Ratio
-41.4458.29---
Upgrade
EV/FCF Ratio
-41.5778.132365.30--
Upgrade
Debt / Equity Ratio
1.031.150.120.200.110.12
Upgrade
Debt / EBITDA Ratio
4.164.220.457.74--
Upgrade
Debt / FCF Ratio
4.684.660.6518.17--
Upgrade
Asset Turnover
0.650.660.990.770.270.30
Upgrade
Inventory Turnover
1.051.041.101.141.002.00
Upgrade
Quick Ratio
12.5010.615.934.628.378.44
Upgrade
Current Ratio
13.8111.767.255.549.639.03
Upgrade
Return on Equity (ROE)
24.73%24.96%57.36%-3.91%-31.41%-45.80%
Upgrade
Return on Assets (ROA)
8.68%9.38%15.65%-0.18%-16.29%-22.71%
Upgrade
Return on Capital (ROIC)
9.41%10.32%18.03%-0.20%-17.61%-24.83%
Upgrade
Return on Capital Employed (ROCE)
10.90%11.40%21.30%---
Upgrade
Earnings Yield
-2.10%2.91%-0.14%-1.85%-3.79%
Upgrade
FCF Yield
-2.35%1.25%0.04%-2.33%-3.85%
Upgrade
Buyback Yield / Dilution
-0.95%-0.86%-7.93%-6.08%-38.42%-1260.47%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q